American Journal of Epidemiology Vol. 93, No. 5: 346-353
Copyright © 1971 by The Johns Hopkins University School of Hygiene and Public Health
other |
EPIDEMIOLOGY OF SULFONAMIDE-RESISTANT MENINGOCOCCAL INFECTIONS IN A CIVILIAN POPULATION1
3Departments of Medicine and Microbiology, University of Florida College of Medicine, Gainesville, Florida. Recipient Research Career Development Award I-K3-AI-38636, National Institutes of Health, and Scholarship in Academic Medicine, The John and Mary R. Markle Foundation, New York, N. Y.
4Department of Health Jacksonville, Florida
Foster, M. T. (Washington Univ. Medical Service, 1515 Lafayette St., St. Louts, Missouri 63104), E. Sanders and M. Ginter). Epidemiology of sulfonamide-reslstant meningococcal infections in a civilian population. Amer J Epidem 93: 346–353, 1971.—An outbreak of infections due to Group B, sulfadiazine-resistant meningococci occurred among residents of a well-circumscribed area within the city of Jacksonville, Florida. Distinguishing features of the outbreak were: lengthy duration; high fatality rate; geographic clustering of cases; and tendency for multiple cases to occur among related, crowded individuals. High rates of asymptomatic carriage of meningococci were found among individuals of low socioeconomic status residing in densely populated areas. High rate of carriage of the epidemic Group B, sulfonamide-resistant strain was found only in household contacts of cases. Low rate of carriage of meningococci and absence of the epidemic strains were noted among those of higher socioeconomic status residing in less densely populated areas of the city. Penicillin was of no value in elimination of meningococci from carriers or in prevention of disease.
carrier state; epidemiology; meningococcal infections; meningococci
1From the Departments of Medicine and Microbiology, University of Florida College of Medicine, Gainesville, and The City of Jacksonville Department of Health, Jacksonville, Florida. Supported in part by National Institutes of Health Research Grant No. AI-06514 and Training Grant No. 5-T01-AI-00341, Bethesda, Md.
2Present address: Department of Medicine, Washington University School of Medicine, St. Louis, Mo.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. H. Harrison Prospects for Vaccine Prevention of Meningococcal Infection Clin. Microbiol. Rev., January 1, 2006; 19(1): 142 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. COHEN, A. C. STEERE, R. BALTIMORE, A. von GRAEVENITZ, E. PANTELICK, B. CAMP, and R. K. ROOT Possible Nosocomial Transmission of Group Y Neisseria meningitidis Among Oncology Patients Ann Intern Med, July 1, 1979; 91(1): 7 - 12. [Abstract] [PDF]
|
|
|
|
 |
|
 The Meningococcal Disease Surveillance Group Meningococcal Disease: Secondary Attack Rate and Chemoprophylaxis in the United States, 1974 JAMA, January 19, 1976; 235(3): 261 - 265. [Abstract] [PDF]
|
|